We Can Medicines Co., Ltd.(TW:6929)
NT$20.85+0.10 (+4.51%)
TW:6929
We Can Medicines Co., Ltd. financials statements
NT$20.85
At close:+0.10 (+4.51%)
We Can Medicines Co., Ltd. (6929) Financial Statements
We Can Medicines Co., Ltd. Financial Overview
We Can Medicines Co., Ltd.'s market cap is currently NT$940.13M. The company's EPS TTM is NT$-1.73; its P/E ratio is -12.05; and it has a dividend yield of 0.41%. We Can Medicines Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 3.22B | NT$ 3.27B | NT$ 3.12B | NT$ 3.30B | NT$ 2.79B |
| Gross Profit | NT$ 747.34M | NT$ 1.10B | NT$ 1.02B | NT$ 1.11B | NT$ 916.55M |
| Operating Income | NT$ -68.02M | NT$ -50.13M | NT$ 42.66M | NT$ 144.16M | NT$ 53.32M |
| EBITDA | NT$ 252.68M | NT$ 288.21M | NT$ 321.25M | NT$ 393.76M | NT$ 266.99M |
| Net Income | NT$ -73.21M | NT$ -47.18M | NT$ 14.80M | NT$ 100.05M | NT$ 38.79M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 285.75M | NT$ 305.67M | NT$ 160.53M | NT$ 216.26M | NT$ 203.36M |
| Total Assets | NT$ 2.98B | NT$ 3.09B | NT$ 2.86B | NT$ 2.58B | NT$ 2.21B |
| Total Debt | NT$ 1.20B | NT$ 1.24B | NT$ 1.32B | NT$ 1.06B | NT$ 901.50M |
| Net Debt | NT$ 952.24M | NT$ 935.84M | NT$ 1.16B | NT$ 847.70M | NT$ 698.14M |
| Total Liabilities | NT$ 1.93B | NT$ 1.97B | NT$ 2.04B | NT$ 1.78B | NT$ 1.53B |
| Stockholders' Equity | NT$ 1.05B | NT$ 1.12B | NT$ 816.35M | NT$ 791.69M | NT$ 684.54M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 220.08M | NT$ 191.44M | NT$ 45.89M | NT$ 223.75M | NT$ 114.20M |
| Operating Cash Flow | NT$ 255.60M | NT$ 260.68M | NT$ 139.84M | NT$ 346.67M | NT$ 457.15M |
| Investing Cash Flow | NT$ -35.72M | NT$ -69.04M | NT$ -99.07M | NT$ -128.45M | NT$ -345.76M |
| Financing Cash Flow | NT$ -240.27M | NT$ -46.50M | NT$ -97.12M | NT$ -205.32M | NT$ -28.21M |
Currency in TWD
